Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. MU
8. DFTX
9. HOOD
10. IBM

Go back to Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
(NASDAQ: AKTS) Delayed: 24.79 +0.70 (2.91%)
Previous Close $24.09    52 Week High $5.77 
Open $24.35    52 Week Low $1.51 
Day High $25.34    P/E N/A 
Day Low $24.14    EPS $0.00 
Volume 361,646